APPLICATIONS PUBLISHED 15 JUNE 2005

Inhibitors of FTSZ and uses thereof
Southern Research Institute 1538907*

Novel substituted benzimidazole dosage forms and method for using same
The Curators of the University of Missouri 1538908*

Devices delivering therapeutic agents and methods regarding the same
Avantec Vascular Corp 1539041*

Reversed liquid crystalline phases with non-paraffin hydrophobes
Lyotropic Therapeutics 1539099*

Compsns and methods for the treatment of skin disorders
Dermipsor 1539100*

Injectable multimodal polymer depot compsns and uses thereof
ALZA 1539101*

Pharmaceutically active lipid based formulations of SN38
Neopharm 1539102*

Methods of treating idiopathic pulmonary fibrosis
Intermune 1539103*

Use of IV emulsions with different triglyceride compsn, particle size and apolipoprotein E for targeted tissue delivery of hydrophobic compounds
The Trustees of Columbia University in the City of New York 1539104*

Compsns and methods for treating skin conditions
Akpharma 1539106*

Buccal polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
Novadel Pharma 1539016*

Buccal, polar and non-polar spray or capsule containing drugs for treating pain
Novadel Pharma 1539107*

Vesicle-encapsulated corticosteroids for the treatment of cancer
Universiteit Utrecht 1539108*

Block copolymer micelle compsn having an enhanced drug-loading capacity and sustained release
Postech Foundation 1539109*

Crystalline drug particles prepared using a controlled precipitation process
Dow Global Technologies 1539110*

Oral dosage forms of water insoluble drugs and methods of making the same
DSM IP Assets 1539111*

Use of an aqueous solution of citric acid and a water-soluble sugar like lactitol as granulation liquid in the manufacture of tablets
Phoqus Pharmaceuticals 1539112*

Modified release ketoprofen dosage form
LEK Pharmaceuticals 1539113*

Film coating for tablets and caplets
Warner-Lambert 1539114*

Methods and dosage forms for controlled delivery of paliperidone
Alza 1539115*

Non-animal product containing veterinary formulations
Merial 1539116*

Formulations of fenofibrate and/or fenofibrate derivatives with improved oral availability
Shire Laboratories 1539117*

Microparticles
Jagotec 1539118*

Palatable controlled-release formulation for companion animals
Pfizer Products 1538119*

Combination of an IBAT inhibitor and a metal salt for the treatment of diarrhoea
AstraZeneca 1539120*

Methods for promoting osteogenesis
Scios 1539121*

Aqueous 2,6-diisopropylphenol pharmaceutical compsns
Transform Pharmaceuticals 1539122*

Use of a combination of DPPE with other chemotherapeutic agents for the treatment of breast cancer
The University of Manitoba 1539123*

Compsns and kits for the removal of irritating compounds from bodily surfaces
Neurogesx 1539124*

A compsn comprising phytospingosine derivatives for apoptosis induction
Kim, Tae-Yoon 1539125*

Pharmaceutical forms of modafinil
Cephalon 1539126*

Method for treating osteoarthritis
Warner-Lambert 1539127*

Use of skin-protecting substances
Phenion 1539128*

Dosage forms and related therapies
Protemix Corp 1539129*

Percutaneous and perungual delivery system
Connetics Australia 1539130*

Tetrapropylammonium tetrathiomolybdate and related compounds for anti-angiogenic therapies
The Regents of the University of Michigan 1539131*

Use of 2,3-alkylcarbonyloxybenzoic acids, derivatives and analogues therefrom in the treatment of tissue and cellular damage and injury in mammals
Advanced Life Sciences 1539132*

Aminocyclohexane quinolines and their azaisosteric analogues with antibacterial activity
Glaxo Group 1539133*

Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compsns and methods of use
Nitromed 1539134*

Treatment of dyskinesia
Motac Neuroscience 1539135*

PPAR alpha selective compounds for the treatment of dyslipidaemia and other lipid disorders
Merck 1539136*

PPAR alpha selective compounds for the treatment of dyslipidaemia and other lipid disorders
Merck 1539137*

Therapeutic process for the treatment of obesity and associated metabolic disorders
Gematria Sciences 1539138*

Compsns and methods for separating amines and amino acids from their counter-enantiomers
IBC Advanced Technologies 1539139*

Carvediol hydrobromide
SB Pharmco Puerto Rico 1539140*

-3 (sulphonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases
Boehringer Ingelheim Pharma 1539141*

Use of an amyloid beta vaccination in combination with a selective COX-2 inhibitor for the treatment of Alzheimer's disease
Pharmacia 1539142*

Leflunomide analogues for treating rheumatoid arthritis
Unitech Pharmaceuticals 1539143*

Multistage formulation containing a biguanide and a thiazolidinedione derivative
Andrx Labs 1539144*

Method of treating tremors
Eisai 1539145*

Dispersible tablets for oral administration
Ranbaxy Laboratories 1539146*

Methods of treating microbial infections in humans and animals
Fasgen; The Johns Hopkins University 1539147*

Bicifadine formulation
Nascime 1539148*

MGLU receptors antagonists for treating disorders associated with MGLU receptors including addiction and depression
Novartis 1539149*

Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof
Chemgenex Pharmaceuticals 1539150*

Biaryl compounds having anti-infective activity
Genesoft Pharmaceuticals 1539151*

Development of muscle mass in a mammal
Neutraceutical Development Corp 1539152*

Therapeutic treatment for the metabolic syndrome and type 2 diabetes
Gematria Sciences 1539153*

Methods for regulating transcription by targeting quadruplex DNA
The Arizona Board of Regents, on behalf of the University of Arizona 1539154*

Stable cream preparations of phenyl-pyridone compounds for topical application
Mepha 1539155*

Liquid dosage forms of acid labile drugs
Abbott Laboratories 1539156*

Method of inhibition choroidal neovascularisation
Trustees of the University of Pennsylvania 1539157*

Aryl piperisine derivatives as inducers of LDL-receptor expression for the treatment of hypercholesterolemia
Glaxo Group 1539158*

Sulphonylpiperidine derivatives containing an aryl or heteroaryl group for use as matrix metalloproteinase inhibitors
AstraZeneca 1539159*

Piperidin-2,6-dione pamoate salts and their use for the treatment of stress-related affective disorders
Prestwick Pharmaceuticals 1539160*

Novel salt and polymorphs of desloratidine hemifumarate
Sandoz 1539161*

Method for improving the ability of patients suffering from lung diseases to participate in and benefit from pulmonary rehabilitation programs
Boehringer Ingelheim Pharma 1539162*

4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors
Warner-Lambert 1539163*

2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors
Altana Pharma 1539164*

Sustained-release tablet compsn comprising a dopamine receptor agonist
Pharmacia Corp 1539165*

Pharmaceutical compsns comprising dextromethorphan and quinidine for the treatment of neurological disorders
Avanir Pharmaceuticals 1539166*

Ciprofloxacin HCI
Janitzek, Robert 1539167*

Treatment of neuropathic pain with 6H-pyrrolo(3,4-D)pyridazine compounds
Merck 1539168*

Amyotrophic lateral sclerosis treatment with cyclooxygenase-2 inhibitors
Pharmacia 1539169*

Stabilised formulations of alpha adrenergic receptor antagonists and uses thereof
Novalar Pharmaceuticals 1539170*

Use of chymase inhibitors for the prevention and/or treatment of arterio-venous graft failure
Societe de Conseils de Recherches et d'Applications Scientifiques 1539171*

New therapeutic uses of (4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl) thieno[2,3-D]pyrimidine
Arachnova Therapeutics 1539172*

Fast dissolving and taste masked oral dosage form comprising sildenafil
Phoqus Pharmaceuticals 1539173*

Use of PDE IV inhibitors to treat angiogenesis
Alcon Manufacturing 1539174*

Substituted indolealkanoic acids derivative and formulations containing same for use in treatment of diabetic complications
The Institutes for Pharmaceutical Discovery 1539175*

Thiazine and oxazine derivatives as MMP-13 inhibitors for treating arthritis
Warner-Lambert 1539176*

Compsns and methods for treating heart disease
Crackower, Michael; Penninger, Josef 1539177*

Protease inhibitors
SmithKline Beecham 1539178*

Angiogenesis inhibition by cephalotaxine alkaloids, derivatives, compsns and uses thereof
Chemgenex Pharmaceuticals 1539179*

Compounds, compsns and methods
Cytokinetics 1539180*

Method of treating lower urinary tract disorders
Dynogen Pharmaceuticals 1539181*

Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration
Alcon 1539182*

Therapeutic treatment methods
Hollis-Eden Pharmaceuticals 1539183*

Estrogen replacement regimen
Casper, Robert; Kopernik, Gideon; Shosham, Zeev 1539184*

Methods and compsns for stimulating bone growth using nitric oxide releasing bisphosphonate conjugates (NO-bisphosphonate)
Osteoscreen 1539185*

Combination therapy comprising a bisphoshonate and a HMG-CoA reductase inhibitor
Novartis 1539186*

Cosmetic compsns comprising calcium silicates
JM Huber 1539187*

Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase
Marck; Isis Pharmaceuticals 1539188*

Method of using anti-apoptotic factors in gene expression
The Trustees of Boston University 1539189*

Biosynthesis of HIF
The General Hospital Corp 1539190*

Glycoalkaloid compsns and various uses thereof
Solbec Pharmaceuticals 1539191*

Compsn and kit for the treatment of inflammatory bowel diseases
Medicarn 1539192*

Compsn of hyaluronic acid and methods of use
Pericor Science 1539193*

Cancer therapy using beta-glucan and antibodies
University of Louisville Research Foundation 1539194*

Use of prebiotics for the treatment and prevention of hyperglycaemic syndromes
Institut National de la Recherche Agronomique 1539195*

Vitreoretinal tamponades based of fluorosilicone fluids
Bausch & Lomb 1539196*

Treatment of tumour cells for use in the immunotherapy of cancer
Thomas Jefferson University 1539197*

Lentiviral vector-mediated gene transfer and uses thereof
Research Development Foundation 1539198*

Methods and compsns for in vivo clearance of pathogens
Cygene 1539199*

Methods for the treatment of multiple sclerosis
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services 1539200*

Antipyrotic and method of manufacturing the same
Nam, Jong-Hyun 1539201*

Method for cancer therapy using herbal extracts
Sterogene Bioseparations 1539202*

Echinacea angustifolia extracts
Indena 1539203*

Plant extracts for treatment of angiogenesis and metastasis
Biopharmacopae Design International 1539204*

Method for the preparation of phytoprogestogenic extracts from Rhizoma ligusticum chuanxiong and uses thereof
National University of Singapore 1539205*

Cosmetic or dermatological preparations having a content of anti-freezing proteins and/or anti-freezing glycoproteins
Beiersdorf 1539206*

Treatment of cell proliferative disorders with chlorotoxin
Transmolecular 1539207*

Compsns and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds
Nastech Pharmaceutical 1539208*

Compsns and methods for synthesising nucleic acids
Invitrogen 1539209*

Modified GLP-1 receptor agonists and their pharmacological methods of use
Bayer Pharmaceuticals 1539210*

Method of up-regulating tumour antigen expression using thymalfasin
Sciclone Pharmaceuticals 1539211*

Methods and compsns for preventing oxidative degradation of proteins
Medarex 1539212*

Cardioprotective therapies based on enzymatic elimination of lipid peroxides by allene oxide synthase
Arizona Board of Regents 1539213*

Thrombin peptide derivatives
The Board of Regents, The University of Texas System 1539214*

Adjuvant-free peptide vaccines
City of Hope 1539215*

Labelled somatostatin analogues backbone cyclised through metal complexation
Yissum Research Development Company of the Hebrew University of Jerusalem 1539216*

Methods for identification of compounds modulating insulin resistance
Biovitrum 1539217*

Compsns and methods for modulating lymphocyte activity
The Regents of the University of California; Washington University 1539218*

Affinity small molecules for the EPO receptor
Receptron 1539219*

Compsns and method for enhanced mucosal delivery of interferon beta
Nastech Pharmaceutical Company 1539220*

Transferrin fusion protein libraries
Biorexis Pharmaceutical 1539221*

Treatment for eye disorder
The Regents of the University of California; The California Institute of Technology 1539222*

Using heat shock proteins and alpha-2-macroglobulins to increase immune response to vaccines comprising heat shock proteins-peptide complexes or alpha-2-macroglobulin-peptide complexes
The University of Connecticut Health Center 1539223*

Antimicrobial compsns and method for use
Inovatech BioProducts 1539224*

Apparatus and methods for enzymatic excharotomy in burn induced compartment syndrome
Mediwound 1539225*

Papaine containing pharmaceutical formulation resp. its use
Santana, Cristiano Alberto Ribeiro 1539227*

Novel compsn and methods for the treatment of immune related diseases
Genentech 1539228*

Administration of therapeutic viruses
Wellstat Biologics 1539230*

Immunisation against autologous ghrelin
Pharmexa 1539232*

Methods of preventing or treating cell malignancies by administering CO2 antagonists
Medimmune 1539234*

Antibodies that specifically bind to REG IV
Human Genome Sciences 1539235*

Compsns, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof
The Trustees of the University of Pennsylvania 1539236*

Methods and compsns for treating T-cell mediated inflammatory/autoimmune diseases and disorders in subjects having a glucocorticoid regulation deficiency
The Washington University 1539240*

Method of controlling pharmacokinetics of immunomodulatory compounds
Becton, Dickinson & Company 1539241*

A compsn and method to augment and sustain neurotransmitter production
Shell, William; Charuvastra, Elisabeth 1539242*

Amino-propanol derivatives
Novartis 1539674*

Aryl and heteroaryl propene amides, derivatives thereof and therapeutic uses thereof
Temple University of the Commonwealth System of Higher Education 1539675*

3,4-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
Schering 1539678*

Oxime and/or hydrazine containing nitrosylated cyclooxygenase-2 selective inhibitors, compsns and methods of use
Nitromed 1539679*

non-halogenated antibacterial agents and processes for making same
Procter & Gamble 1539681*

Processes for the synthesis of intermediates useful for the synthesis of tubulin inhibitors
Wyeth Holdings 1539682*

Phenil derivatives and their use as rotomase inhibitors
Jerini 1539683*

Benzenesulphonamides and process for their preparation
Richter Gedeon Vegyeszeti Gyar 1539684*

MCP-1 receptor antagonists and method of use thereof
Warner-Lambert 1539685*

Inhibitor of Factor XA and other serine proteases involved in the coagulation cascade
Warner-Lambert 1539686*

Substituted gkycine derivatives for use as medicaments
Pfizer 1539687*

Novel compounds comprising a thiocarbonyl-sulphanyl group, which can be used for the radical synthesis of alpha-perfluoroalkylamines
Rhodia Chimie 1539688*

• Antisense modulation of endothelial lipase expression
Pharmacia 1539689*